Physician profile
David Ho
NPI 1215937586
$4,522.94
in general payments reported to CMS, 2019-2025
39 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $494 · 2021: $808 · 2022: $866 · 2023: $545 · 2024: $525 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.50 |
| Education | $179.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,068.22 | 2019-2025 | Xtandi |
| Pfizer INC. | $594.34 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $384.27 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $310.42 | 2019-2025 | Erleada |
| Abbott Laboratories | $180.79 | 2025 | Proclaim |
| 180 Medical, INC. | $148.69 | 2019-2025 | |
| Urovant Sciences INC | $132.46 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.99 | 2020-2023 | |
| Boston Scientific Corporation | $123.90 | 2019-2021 | |
| Convatec INC. | $116.14 | 2021-2022 | |
| Antares Pharma, INC. | $113.92 | 2021-2023 | Xyosted, Nocdurna, Tlando |
| Abbvie INC. | $102.63 | 2019-2022 | |
| Abc Home Medical Supply, INC. | $101.33 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $88.26 | 2019-2021 | |
| Urogen Pharma, INC. | $85.49 | 2021-2023 | Jelmyto |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $77.73 | 2021 | |
| Verity Pharmaceuticals INC. | $76.49 | 2024-2025 | Trelstar, Tlando |
| Teleflex LLC | $76.26 | 2022-2023 | Urolift |
| Endo USA, INC. | $73.46 | 2024-2025 | Aveed, Xiaflex |
| Accord Healthcare, INC. | $63.80 | 2022-2023 | |
| Dendreon Pharmaceuticals LLC | $51.35 | 2023-2025 | Provenge |
| Checkpoint Surgical, INC | $40.75 | 2024 | Checkpoint Stimulators |
| Halozyme INC | $37.14 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $36.36 | 2022-2024 | Bard Urinary Drainage Bag |
| Myriad Genetic Laboratories, INC. | $32.28 | 2022-2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $29.57 | 2022 | |
| Laborie Medical Technologies Corp. | $25.18 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Novo Nordisk INC | $23.63 | 2024 | Rivfloza |
| Procept Biorobotics Corporation | $23.41 | 2020 | |
| Merck Sharp & Dohme LLC | $22.95 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.71 | 2024 | Adstiladrin |
| Hollister Incorporated | $21.82 | 2022 | |
| Ambu INC. | $19.60 | 2022 | |
| Smith+Nephew, INC. | $19.11 | 2024 | Oasis, Stravix Pl |
| Kowa Pharmaceuticals America, INC. | $17.04 | 2022 | |
| Tolmar, INC. | $15.65 | 2025 | Jatenzo, Eligard |
| Innovation Technologies INC | $15.02 | 2025 | Irrisept |
| Sagent Pharmaceuticals | $14.70 | 2023 | Glydo |
| Mission Pharmacal Company | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.